Antipsychotic add-on falls off FDA measure

Share this article:
Sen. Herb Kohl (D-WI)
Sen. Herb Kohl (D-WI)


The Senate failed to approve legislation meant to enhance antipsychotic regulations in nursing homes, despite passing the bill to which it was attached.

Sens. Herb Kohl (D-WI), Charles Grassley (R-IA) and Richard Blumenthal (D-CT) proposed a regulation that would have standardized protocols for obtaining informed consent before administering antipsychotics for off-label use. The legislation was proposed as an amendment to an existing Food and Drug Administration reauthorization bill (S. 3187), which passed the Senate by  a nearly unanimous 96-1 vote.

“We need a new policy that helps to ensure that these drugs are being appropriately used to treat people with mental illnesses, not used to curb behavioral symptoms of Alzheimer's or other dementias,” Kohl said.

About 1 in 7 residents had at least one Medicare or Medicaid claim for atypical antipsychotics last year, according to the Office of the Inspector General. 



Share this article:

More in News

RACs collected nearly $2 million from skilled nursing facilities last year, report ...

Recovery Audit Contractors recovered $1.8 million in Medicare overpayments made to skilled nursing facilities in fiscal year 2013, according to a Congressional report released Monday.

OK nursing home worker threatened to behead colleague in a terrorist act, ...

Police in Oklahoma City have arrested a nursing home worker who allegedly threatened to behead another staff member out of solidarity with the Islamic State in Iraq and Syria, according to news sources.

Jewish Home Lifecare named Innovator of the Year

Jewish Home Lifecare named Innovator of the Year

Jewish Home Lifecare won the top award in the Innovator of the Year category in the third annual McKnight's Excellence in Technology Awards competition.